Cardlytics, which provides marketing analytics to advertisers based on consumer payment activity, announced terms for its IPO on Monday.
The Atlanta, GA-based company plans to raise $76 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Cardlytics would command a fully diluted market value of $285 million.
Cardlytics was founded in 2008 and booked $128 million in sales for the 12 months ended September 30, 2017. It plans to list on the Nasdaq under the symbol CDLX. BofA Merrill Lynch, J.P. Morgan, Wells Fargo Securities and SunTrust Robinson Humphrey are the joint bookrunners on the deal. It is expected to price during the week of February 5, 2018.
